News center | Australia

Sep 23, 2021

Philips partners with Healius Pathology to deploy a multisite Digital Pathology solution    

Healius Pathology, through its National Pathology Network, installs Philips IntelliSite Pathology Solution, a leading digital pathology solution to support its customers, pathologists and patients.


Sydney, Australia – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has partnered with Healius Pathology, one of Australia's leading providers of private medical laboratory and pathology services, to deploy a multisite digital pathology solution using Philips' industry-leading IntelliSite Pathology Solution.

Limited in time and resources and expected to accomplish more at lower costs, pathology departments need to find new ways to adapt. Before the pandemic, diagnostic services were already burdened with high demand, and inefficient workflows. In the face of COVID-19, the need for greater efficiency and responsiveness has become even more urgent. As a result, pathology is beginning to transform into a digital discipline, bringing exciting new possibilities that can aid, streamline, and enhance diagnostic and clinical decision making – so labs can continue to meet the highest standards and help drive healthcare transformation forward.


Digital pathology aims to reduce pressure on pathology services by streamlining workflow and extending collaboration to increase diagnostic confidence. The Philips IntelliSite Pathology Solution is highly scalable with proven technology that enhances productivity with high-resolution digital images, collaborative features, and case management tools. It is designed to support clinical practice, improve patient care, and reduce healthcare costs.


The solution will initially be rolled out through Healius Pathology's National Pathology Division with the ultimate goal of providing easy and immediate access to medical and veterinary pathology information across the business, allowing clinicians to make timely decisions about patient care.


A pathological review of patient tissue has historically been done using a microscope. Pathologists can now gain new insights through real-time collaboration with Image Management System
(IMS) software and algorithms designed to aid, streamline, and maximise diagnostic confidence. Using the Philips IntelliSite Pathology Solution, Healius pathologists can digitise their workflow with consistently high image quality and fast first time-right scanning capabilities.

Deanne Broughton, General Manager of Healius Pathology’s Veterinary division, SVS Pathology Network, is excited about the new solution's quality and versatility: "It is an exciting time for our national veterinary business to begin the rollout of this new digital pathology solution. This new solution will deliver many things for our business, with the most important being simplicity and ease for our practitioners and our patients. We look forward to collaborating with Philips in bringing this solution to life across our national network.”

John McKechnie, Healius Pathology CEO, shares Deanne’s enthusiasm about the new Digital Pathology solution and what it will mean for practitioners and patients across the business adding: "Our goal is to implement digital pathology in our laboratories to create a fully digital multisite network. Once deployed across our business, the new solution will create a virtual pathology network that will reinvent the pathologist experience, improving turnaround time and enabling increased quality and versatility of the digital image provided to pathologists for interpretation and diagnosis."

"Philips is using its unique position as a long-established innovator focused on serving our customers' needs with many solutions to bring together people, technology and data into a more seamless workflow across the health continuum," said Matt Moran, Managing Director of Philips in Australia & New Zealand. "Through the digitisation of pathology, we aim to break boundaries, reduce complexity, and deliver meaningful innovation to help our customers achieve diagnostic confidence and better patient care".  

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found on our news center.

Click here to read moreClick here to read less



Sarah AL Hashimi

Sarah Al-Hashimi

Corporate Communications Manager

Philips, Australia & New Zealand


You are about to visit a Philips global content page


Media assets

Share on social media

More related news

You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.